Bristol Myers Squibb has tapped up Faro to use AI to improve the Big Pharma's clinical trial protocols. | Bristol Myers ...
Bristol Myers Squibb is adding three prescription medications on TrumpRx.gov on Monday, offering discounts of up to 90%, FOX ...
Promotional materials for a handful of biologics have found their way into the FDA’s hot seat. | Promotional materials for a ...
BMS's Opdivo has received approvals for two new indications in cHL from the US FDA and the EC, expanding its use for both ...
InvestorsHub on MSN
Bristol Myers Squibb broadens multiple myeloma care initiative after nearly a decade
Bristol Myers Squibb (NYSE:BMY) announced plans to expand its Standing in the Gaap program, an initiative focused on ...
This pharma stock should hold up well if the market tanks.
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries. According to the Food and ...
Merck (MRK) said Wednesday it will acquire clinical-stage biotech Terns Pharmaceuticals (TERN) in an all-cash transaction valued at about $6.7 billion, further expanding its oncology pipeline. Against ...
Five immunology assets in-licensed from BMS with potential to address unmet needs for patients with autoimmune diseases, including late-stage asset for lupus Bain Capital leads $300 million financing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results